US3180193A
(en)
|
1963-02-25 |
1965-04-27 |
Benedict David |
Machines for cutting lengths of strip material
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
US4444887A
(en)
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
US4433092A
(en)
|
1981-03-09 |
1984-02-21 |
Champion Spark Plug Company |
Green ceramic of lead-free glass, conductive carbon, silicone resin and AlPO4, useful, after firing, as an electrical resistor
|
US4873191A
(en)
|
1981-06-12 |
1989-10-10 |
Ohio University |
Genetic transformation of zygotes
|
US4474893A
(en)
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
US4714681A
(en)
|
1981-07-01 |
1987-12-22 |
The Board Of Reagents, The University Of Texas System Cancer Center |
Quadroma cells and trioma cells and methods for the production of same
|
US4716111A
(en)
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
DE3586772T2
(de)
|
1984-07-24 |
1993-03-04 |
Coselco Mimotopes Pty Ltd |
Verfahren zur bestimmung von mimotopen.
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
DE3587801T2
(de)
|
1984-12-24 |
1994-10-20 |
Merck & Co Inc |
Zubereitung enthaltend ein saures Fibroblastewachstumfaktor (aFGF).
|
US5049386A
(en)
|
1985-01-07 |
1991-09-17 |
Syntex (U.S.A.) Inc. |
N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
US4946787A
(en)
|
1985-01-07 |
1990-08-07 |
Syntex (U.S.A.) Inc. |
N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
US4897355A
(en)
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
US4631211A
(en)
|
1985-03-25 |
1986-12-23 |
Scripps Clinic & Research Foundation |
Means for sequential solid phase organic synthesis and methods using the same
|
EP0216846B2
(de)
|
1985-04-01 |
1995-04-26 |
Celltech Limited |
Transformierte myeloma-zell-linie und dieselbe verwendendes verfahren zur expression eines gens, das ein eukaryontisches polypeptid kodiert
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
WO1987001130A1
(en)
|
1985-08-15 |
1987-02-26 |
Stauffer Chemical Company |
Tryptophan producing microorganism
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
LU86128A1
(fr)
|
1985-10-18 |
1987-06-02 |
Vander Poorten Henri |
Procede permettant l'impression ou le revetement de ceramique simultanement a son electroformage et conduisant en monocuisson a des produits decoratifs ou techniques
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
US5073492A
(en)
|
1987-01-09 |
1991-12-17 |
The Johns Hopkins University |
Synergistic composition for endothelial cell growth
|
WO1988007089A1
(en)
|
1987-03-18 |
1988-09-22 |
Medical Research Council |
Altered antibodies
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
JPS6438100A
(en)
|
1987-07-31 |
1989-02-08 |
Toray Industries |
Vascular endothelial cell growth factor
|
JPS6438100U
(de)
|
1987-08-26 |
1989-03-07 |
|
|
DE3852823T2
(de)
|
1987-09-11 |
1995-05-24 |
Whitehead Biomedical Inst |
Transduktionsveränderte fibroblasten und ihre anwendung.
|
US5336603A
(en)
|
1987-10-02 |
1994-08-09 |
Genentech, Inc. |
CD4 adheson variants
|
GB8725529D0
(en)
|
1987-10-30 |
1987-12-02 |
Delta Biotechnology Ltd |
Polypeptides
|
GB8809129D0
(en)
|
1988-04-18 |
1988-05-18 |
Celltech Ltd |
Recombinant dna methods vectors and host cells
|
EP0428534B1
(de)
|
1988-06-14 |
1995-03-29 |
Cetus Oncology Corporation |
Kupplungsmittel und sterisch gehinderte, mit disulfid gebundene konjugate daraus
|
PT90959B
(pt)
|
1988-06-24 |
1995-05-04 |
Dow Chemical Co |
Processo para a preparacao de quelantes macrociclicos bifuncionais, de seus complexos e seus conjugados com anticorpos
|
US5756065A
(en)
|
1988-06-24 |
1998-05-26 |
The Dow Chemical Company |
Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents
|
US4925648A
(en)
|
1988-07-29 |
1990-05-15 |
Immunomedics, Inc. |
Detection and treatment of infectious and inflammatory lesions
|
US5601819A
(en)
|
1988-08-11 |
1997-02-11 |
The General Hospital Corporation |
Bispecific antibodies for selective immune regulation and for selective immune cell binding
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
IL91501A
(en)
|
1988-09-02 |
1998-03-10 |
Dyax Corp |
Generation of a variegated library of mutant potential binding proteins and screening of said library for proteins with a desired binding activity
|
JPH02117698A
(ja)
|
1988-10-27 |
1990-05-02 |
Toray Ind Inc |
血管内皮細胞成長因子
|
KR900005995A
(ko)
|
1988-10-31 |
1990-05-07 |
우메모또 요시마사 |
변형 인터류킨-2 및 그의 제조방법
|
US5240848A
(en)
|
1988-11-21 |
1993-08-31 |
Monsanto Company |
Dna sequences encoding human vascular permeability factor having 189 amino acids
|
JP2989002B2
(ja)
|
1988-12-22 |
1999-12-13 |
キリン―アムジエン・インコーポレーテツド |
化学修飾顆粒球コロニー刺激因子
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5096815A
(en)
|
1989-01-06 |
1992-03-17 |
Protein Engineering Corporation |
Generation and selection of novel dna-binding proteins and polypeptides
|
US5198346A
(en)
|
1989-01-06 |
1993-03-30 |
Protein Engineering Corp. |
Generation and selection of novel DNA-binding proteins and polypeptides
|
US5693622A
(en)
|
1989-03-21 |
1997-12-02 |
Vical Incorporated |
Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
ATE277193T1
(de)
|
1989-03-21 |
2004-10-15 |
Vical Inc |
Expression von exogenen polynukleotidsequenzen in wirbeltieren
|
EP0394827A1
(de)
|
1989-04-26 |
1990-10-31 |
F. Hoffmann-La Roche Ag |
Chimärische CD4-Immunoglobulin-Polypeptide
|
US5766883A
(en)
|
1989-04-29 |
1998-06-16 |
Delta Biotechnology Limited |
Polypeptides
|
IE63847B1
(en)
|
1989-05-05 |
1995-06-14 |
Res Dev Foundation |
A novel antibody delivery system for biological response modifiers
|
EP0399816B1
(de)
|
1989-05-24 |
1995-12-20 |
Merck & Co. Inc. |
Reinigung und Charakterisierung eines von einem Glioma abstammenden Wachstumsfaktors
|
EP0739904A1
(de)
|
1989-06-29 |
1996-10-30 |
Medarex, Inc. |
Bispezifische Reagenzien für die AIDS-Therapie
|
US5112946A
(en)
|
1989-07-06 |
1992-05-12 |
Repligen Corporation |
Modified pf4 compositions and methods of use
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
US5219739A
(en)
|
1989-07-27 |
1993-06-15 |
Scios Nova Inc. |
DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
|
US5194596A
(en)
|
1989-07-27 |
1993-03-16 |
California Biotechnology Inc. |
Production of vascular endothelial cell growth factor
|
FR2650598B1
(fr)
|
1989-08-03 |
1994-06-03 |
Rhone Poulenc Sante |
Derives de l'albumine a fonction therapeutique
|
US5073627A
(en)
|
1989-08-22 |
1991-12-17 |
Immunex Corporation |
Fusion proteins comprising GM-CSF and IL-3
|
US5436146A
(en)
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
AU638762B2
(en)
|
1989-10-05 |
1993-07-08 |
Optein Inc |
Cell-free synthesis and isolation of novel genes and polypeptides
|
WO1991006570A1
(en)
|
1989-10-25 |
1991-05-16 |
The University Of Melbourne |
HYBRID Fc RECEPTOR MOLECULES
|
GB8924021D0
(en)
|
1989-10-25 |
1989-12-13 |
Celltech Ltd |
Recombinant dna method and vectors for the use therein
|
US5676954A
(en)
|
1989-11-03 |
1997-10-14 |
Vanderbilt University |
Method of in vivo delivery of functioning foreign genes
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
AU7247191A
(en)
|
1990-01-11 |
1991-08-05 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
DE69133566T2
(de)
|
1990-01-12 |
2007-12-06 |
Amgen Fremont Inc. |
Bildung von xenogenen Antikörpern
|
US5314995A
(en)
|
1990-01-22 |
1994-05-24 |
Oncogen |
Therapeutic interleukin-2-antibody based fusion proteins
|
US5747334A
(en)
|
1990-02-15 |
1998-05-05 |
The University Of North Carolina At Chapel Hill |
Random peptide library
|
FI90454C
(fi)
|
1990-02-22 |
1994-02-10 |
Patenttitoimisto T Poutanen Oy |
Menetelmä naulalevykattotuolin valmistamiseksi
|
AU654811B2
(en)
|
1990-03-20 |
1994-11-24 |
Trustees Of Columbia University In The City Of New York, The |
Chimeric antibodies with receptor binding ligands in place of their constant region
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
WO1991018088A1
(en)
|
1990-05-23 |
1991-11-28 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Adeno-associated virus (aav)-based eucaryotic vectors
|
US5349053A
(en)
|
1990-06-01 |
1994-09-20 |
Protein Design Labs, Inc. |
Chimeric ligand/immunoglobulin molecules and their uses
|
EP0464533B1
(de)
|
1990-06-28 |
1998-07-29 |
Hoechst Aktiengesellschaft |
Fusionsproteine mit immunglobulinanteilen, ihre Herstellung und Verwendung
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
DE4025687A1
(de)
|
1990-08-14 |
1992-02-20 |
Ruetgerswerke Ag |
Durch strahlung vernetzbare bindemittelgemische
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
DK0814159T3
(da)
|
1990-08-29 |
2005-10-24 |
Genpharm Int |
Transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
|
EP0476983B1
(de)
|
1990-09-21 |
2000-03-15 |
Merck & Co. Inc. |
Wachstumsfaktor II für vaskuläre Endothelzellen
|
US5726152A
(en)
|
1990-09-21 |
1998-03-10 |
Merck & Co., Inc. |
Vascular endothelial cell growth factor II
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
AU660629B2
(en)
|
1990-10-01 |
1995-07-06 |
University Of Connecticut, The |
Targeting viruses and cells for selective internalization by cells
|
JP3583420B2
(ja)
|
1990-10-05 |
2004-11-04 |
メダレツクス・インコーポレーテツド |
二特異的試薬を用いた標的免疫化
|
AU8727291A
(en)
|
1990-10-29 |
1992-06-11 |
Cetus Oncology Corporation |
Bispecific antibodies, method of production, and uses thereof
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
US5353535A
(en)
|
1990-11-05 |
1994-10-11 |
Plumly George W |
Floor type advertising apparatus
|
ATE218889T1
(de)
|
1990-11-09 |
2002-06-15 |
Stephen D Gillies |
Cytokine immunokonjugate
|
WO1992009690A2
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
EP0517895B1
(de)
|
1990-12-14 |
1996-11-20 |
Cell Genesys, Inc. |
Chimärische ketten zur transduktion von rezeptorverbundenen signalwegen
|
DK0536350T3
(da)
|
1991-02-22 |
2002-09-02 |
American Cyanamid Co |
Identifikation af et nyt humant receptor-tyrosinkinase-gen
|
EP0506477B1
(de)
|
1991-03-28 |
1999-06-23 |
Merck & Co. Inc. |
Untereinheit-C des vaskulären endothelialen Zellwachstumsfaktors
|
US5185438A
(en)
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
DK1471142T3
(da)
|
1991-04-10 |
2009-03-09 |
Scripps Research Inst |
Heterodimere receptor-biblioteker under anvendelse af fagemider
|
US5234908A
(en)
|
1991-04-12 |
1993-08-10 |
Creative Biomolecules, Inc. |
Method of treating gastrointestinal ulcers with platelet derived growth factor
|
ES2093778T3
(es)
|
1991-04-26 |
1997-01-01 |
Surface Active Ltd |
Nuevos anticuerpos y metodos para su uso.
|
ATE199647T1
(de)
|
1991-05-14 |
2001-03-15 |
Univ Connecticut |
Gerichtete abgabe von genen, die immunogene proteine kodieren
|
EP0519596B1
(de)
|
1991-05-17 |
2005-02-23 |
Merck & Co. Inc. |
Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
|
WO1992022635A1
(en)
|
1991-06-05 |
1992-12-23 |
University Of Connecticut |
Targeted delivery of genes encoding secretory proteins
|
JPH07503124A
(ja)
|
1991-06-14 |
1995-04-06 |
ゾーマ・コーポレーション |
微生物によって生産される抗体断片とそれらの複合体
|
IL99120A0
(en)
|
1991-08-07 |
1992-07-15 |
Yeda Res & Dev |
Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
US6270989B1
(en)
|
1991-11-05 |
2001-08-07 |
Transkaryotic Therapies, Inc. |
Protein production and delivery
|
US5641670A
(en)
|
1991-11-05 |
1997-06-24 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US5661133B1
(en)
|
1991-11-12 |
1999-06-01 |
Univ Michigan |
Collateral blood vessel formation in cardiac muscle by injecting a dna sequence encoding an angiogenic protein
|
ATE463573T1
(de)
|
1991-12-02 |
2010-04-15 |
Medimmune Ltd |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
AU3434393A
(en)
|
1992-01-17 |
1993-08-03 |
Regents Of The University Of Michigan, The |
Targeted virus
|
US5622929A
(en)
|
1992-01-23 |
1997-04-22 |
Bristol-Myers Squibb Company |
Thioether conjugates
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
US5399349A
(en)
|
1992-02-06 |
1995-03-21 |
Paunescu; Calin |
Treatment of acne
|
US5861301A
(en)
|
1992-02-20 |
1999-01-19 |
American Cayanamid Company |
Recombinant kinase insert domain containing receptor and gene encoding same
|
DK0627940T3
(da)
|
1992-03-05 |
2003-09-01 |
Univ Texas |
Anvendelse af immunokonjugater til diagnose og/eller terapi af vaskulariserede tumorer
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
US5447851B1
(en)
|
1992-04-02 |
1999-07-06 |
Univ Texas System Board Of |
Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
|
AU3940293A
(en)
|
1992-04-03 |
1993-11-08 |
Alexander T. YOUNG |
Gene therapy using targeted viral vectors
|
ZA932522B
(en)
|
1992-04-10 |
1993-12-20 |
Res Dev Foundation |
Immunotoxins directed against c-erbB-2(HER/neu) related surface antigens
|
US5326695A
(en)
|
1992-05-15 |
1994-07-05 |
Ludwig Institute For Cancer Research |
Platelet derived growth factor agonists
|
CA2102401A1
(en)
|
1992-06-09 |
1993-12-10 |
Friedrich Hoppe |
Latch and lockset system
|
ES2301158T3
(es)
|
1992-07-24 |
2008-06-16 |
Amgen Fremont Inc. |
Produccion de anticuerpos xenogenicos.
|
EP0749475A4
(de)
|
1992-08-26 |
1997-05-07 |
Harvard College |
Verwendung des cytokins ip-10 als anti-tumor agenz
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
KR950703640A
(ko)
|
1992-10-09 |
1995-09-20 |
가일 케이,나우톤. |
간 보존 세포(liver reserve cells)
|
US5776755A
(en)
|
1992-10-09 |
1998-07-07 |
Helsinki University Licensing, Ltd. |
FLT4, a receptor tyrosine kinase
|
US6824777B1
(en)
|
1992-10-09 |
2004-11-30 |
Licentia Ltd. |
Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
|
AU694097B2
(en)
|
1992-11-18 |
1998-07-16 |
Arch Development Corporation |
Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
|
TW402639B
(en)
|
1992-12-03 |
2000-08-21 |
Transkaryotic Therapies Inc |
Protein production and protein delivery
|
CA2592997A1
(en)
|
1992-12-03 |
1994-06-09 |
Genzyme Corporation |
Pseudo-adenovirus vectors
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
US5441050A
(en)
|
1992-12-18 |
1995-08-15 |
Neoprobe Corporation |
Radiation responsive surgical instrument
|
US5593972A
(en)
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
US5480971A
(en)
|
1993-06-17 |
1996-01-02 |
Houghten Pharmaceuticals, Inc. |
Peralkylated oligopeptide mixtures
|
US5716981A
(en)
|
1993-07-19 |
1998-02-10 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic compositions and methods of use
|
WO1995015982A2
(en)
|
1993-12-08 |
1995-06-15 |
Genzyme Corporation |
Process for generating specific antibodies
|
JP2552425B2
(ja)
|
1993-12-14 |
1996-11-13 |
コナミ株式会社 |
実況中継機能付きゲーム機
|
US5922572A
(en)
|
1994-01-25 |
1999-07-13 |
Human Genome Sciences, Inc. |
Polynucleotides encoding haemopoietic maturation factor
|
ATE300610T1
(de)
|
1994-01-31 |
2005-08-15 |
Univ Boston |
Bibliotheken aus polyklonalen antikörpern
|
US5834252A
(en)
|
1995-04-18 |
1998-11-10 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
US7109308B1
(en)
|
1994-03-08 |
2006-09-19 |
Human Genome Sciences, Inc. |
Antibodies to human vascular endothelial growth factor 2
|
US7153827B1
(en)
|
1994-03-08 |
2006-12-26 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 and methods of use
|
US5817485A
(en)
|
1994-03-08 |
1998-10-06 |
Human Genome Sciences, Inc. |
Nucleic acids and cells for recombinant production of fibroblast growth factor-10
|
US7186688B1
(en)
|
1994-03-08 |
2007-03-06 |
Human Genome Sciences, Inc. |
Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
|
US5932540A
(en)
*
|
1994-03-08 |
1999-08-03 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US5633147A
(en)
|
1994-03-08 |
1997-05-27 |
Human Genome Sciences, Inc. |
Transforming growth factor αH1
|
US6608182B1
(en)
|
1994-03-08 |
2003-08-19 |
Human Genome Sciences, Inc. |
Human vascular endothelial growth factor 2
|
US6734285B2
(en)
|
1994-03-08 |
2004-05-11 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2 proteins and compositions
|
US6040157A
(en)
|
1994-03-08 |
2000-03-21 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
WO1995024473A1
(en)
|
1994-03-08 |
1995-09-14 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
US5985660A
(en)
|
1994-06-15 |
1999-11-16 |
Systemix, Inc. |
Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
|
AU3382595A
(en)
|
1994-07-29 |
1996-03-04 |
Smithkline Beecham Corporation |
Novel compounds
|
WO1996005856A1
(en)
|
1994-08-23 |
1996-02-29 |
Human Genome Sciences, Inc. |
Human chemokine polypeptides
|
US5652225A
(en)
|
1994-10-04 |
1997-07-29 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Methods and products for nucleic acid delivery
|
US6645933B1
(en)
|
1995-08-01 |
2003-11-11 |
Helsinki University Licensing Ltd. Oy |
Receptor ligand VEGF-C
|
US6403088B1
(en)
|
1995-08-01 |
2002-06-11 |
Helsinki University Licensing, Ltd. |
Antibodies reactive with VEGF-C, a ligand for the Flt4 receptor tyrosine kinase (VEGFR-3)
|
WO1998033917A1
(en)
|
1994-11-14 |
1998-08-06 |
The Ludwig Institute For Cancer Research |
Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
|
US6245530B1
(en)
|
1995-08-01 |
2001-06-12 |
Ludwig Institute For Cancer Research |
Receptor ligand
|
US6818220B1
(en)
|
1994-11-14 |
2004-11-16 |
Licentia Ltd. |
Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereof
|
US6130071A
(en)
|
1997-02-05 |
2000-10-10 |
Helsinki University Licensing, Ltd. |
Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof
|
US6221839B1
(en)
*
|
1994-11-14 |
2001-04-24 |
Helsinki University Licensing Ltd. Oy |
FIt4 ligand and methods of use
|
US6030613A
(en)
|
1995-01-17 |
2000-02-29 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
ATE238668T1
(de)
|
1995-01-17 |
2003-05-15 |
Brigham & Womens Hospital |
Rezeptorspezifischer transepithelialer transport von immunogenen
|
US5652224A
(en)
|
1995-02-24 |
1997-07-29 |
The Trustees Of The University Of Pennsylvania |
Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
|
US5792453A
(en)
|
1995-02-28 |
1998-08-11 |
The Regents Of The University Of California |
Gene transfer-mediated angiogenesis therapy
|
US5607918A
(en)
|
1995-03-01 |
1997-03-04 |
Ludwig Institute For Cancer Research |
Vascular endothelial growth factor-B and DNA coding therefor
|
US5928939A
(en)
|
1995-03-01 |
1999-07-27 |
Ludwig Institute For Cancer Research |
Vascular endothelial growth factor-b and dna coding therefor
|
US5516717A
(en)
|
1995-04-19 |
1996-05-14 |
United Microelectronics Corporation |
Method for manufacturing electrostatic discharge devices
|
EP0822830B1
(de)
|
1995-04-27 |
2008-04-02 |
Amgen Fremont Inc. |
Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
|
AU2466895A
(en)
|
1995-04-28 |
1996-11-18 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US5705151A
(en)
|
1995-05-18 |
1998-01-06 |
National Jewish Center For Immunology & Respiratory Medicine |
Gene therapy for T cell regulation
|
US5804162A
(en)
|
1995-06-07 |
1998-09-08 |
Alliance Pharmaceutical Corp. |
Gas emulsions stabilized with fluorinated ethers having low Ostwald coefficients
|
WO1997000271A1
(en)
|
1995-06-14 |
1997-01-03 |
The Regents Of The University Of California |
Novel high affinity human antibodies to tumor antigens
|
US5811097A
(en)
|
1995-07-25 |
1998-09-22 |
The Regents Of The University Of California |
Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
|
US7727761B2
(en)
|
1995-08-01 |
2010-06-01 |
Vegenics Limited |
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
|
US6361946B1
(en)
|
1997-02-05 |
2002-03-26 |
Licentia Ltd |
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
|
AU725609C
(en)
*
|
1995-08-18 |
2002-01-03 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
EP1382679A3
(de)
|
1995-09-08 |
2004-11-10 |
Genentech, Inc. |
Antagonisten gegen Vaskuläres Endothelzellen Wachstumsfaktor-verwandtes Protein (VRP)
|
GB9601081D0
(en)
|
1995-10-06 |
1996-03-20 |
Cambridge Antibody Tech |
Specific binding members for human transforming growth factor beta;materials and methods
|
US6121246A
(en)
|
1995-10-20 |
2000-09-19 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Method for treating ischemic tissue
|
WO1997017442A1
(en)
|
1995-11-08 |
1997-05-15 |
Immunex Corporation |
Flk-1 binding protein
|
US5641750A
(en)
|
1995-11-29 |
1997-06-24 |
Amgen Inc. |
Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
AU5711196A
(en)
|
1996-03-14 |
1997-10-01 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule i
|
JP2000508522A
(ja)
|
1996-03-22 |
2000-07-11 |
ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド |
アポトーシス誘導分子ii
|
WO1997046251A1
(en)
|
1996-06-06 |
1997-12-11 |
Lajolla Pharmaceutical Company |
aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
|
WO1998006844A1
(en)
|
1996-08-13 |
1998-02-19 |
Human Genome Sciences, Inc. |
Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, kgf-12)
|
CA2263890C
(en)
|
1996-08-23 |
2013-05-14 |
Ludwig Institute For Cancer Research |
Recombinant vascular endothelial cell growth factor d (vegf-d)
|
US6225290B1
(en)
|
1996-09-19 |
2001-05-01 |
The Regents Of The University Of California |
Systemic gene therapy by intestinal cell transformation
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
CA2722378C
(en)
|
1996-12-03 |
2015-02-03 |
Amgen Fremont Inc. |
Human antibodies that bind tnf.alpha.
|
AU5439998A
(en)
|
1996-12-06 |
1998-06-29 |
Zymogenetics Inc. |
Vascular endothelial growth factor
|
ATE296117T1
(de)
|
1997-03-07 |
2005-06-15 |
Wistar Inst |
Verwendung von adenoviralen vektoren, die pdgf oder vegf exprimieren, zur heilung von gewebsdefekten und zur induzierung der hypervaskulität in säugergeweben
|
US7863444B2
(en)
|
1997-03-19 |
2011-01-04 |
Abbott Laboratories |
4-aminopyrrolopyrimidines as kinase inhibitors
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
JP3876002B2
(ja)
|
1997-04-14 |
2007-01-31 |
ミクロメート・アクチエンゲゼルシャフト |
抗ヒト抗原受容体を産生するための斬新な方法およびそれらの使用
|
JP2001524828A
(ja)
|
1997-04-25 |
2001-12-04 |
コラテラル・セラピューティクス |
切断型vegf関連蛋白質
|
WO1998049305A1
(en)
|
1997-05-01 |
1998-11-05 |
Amgen Inc. |
Chimeric opg polypeptides
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
AU745965B2
(en)
*
|
1997-06-06 |
2002-04-11 |
Asat Ag Applied Science & Technology |
Anti-GPIIb/IIIa recombinant antibodies
|
EP0990042A1
(de)
|
1997-06-10 |
2000-04-05 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Regulatorische sequenzen beteiligt an der hypoxia-regulierten genexpression und deren anwendungen
|
EP1000082A2
(de)
*
|
1997-07-08 |
2000-05-17 |
Novopharm Biotech, Inc. |
Antigenbindungsfragmente, genannt 4b5, die spezifisch krebszellen nachweisen, nukleotide die für diese fragmente kodieren, und deren verwendung zur vorbeugung und zum nachweis von krebs
|
AU8905698A
(en)
|
1997-08-15 |
1999-03-08 |
Helsinki University Licensing Ltd Oy |
Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
AU751572B2
(en)
|
1997-10-27 |
2002-08-22 |
Merck & Co., Inc. |
Gene therapy for stimulation of angiogenesis
|
CA2309541C
(en)
|
1997-11-03 |
2011-01-11 |
Human Genome Sciences, Inc. |
Vegi, an inhibitor of angiogenesis and tumor growth
|
JP2002505873A
(ja)
|
1998-03-13 |
2002-02-26 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
血管内皮増殖因子2
|
US5930540A
(en)
*
|
1998-07-01 |
1999-07-27 |
Eastman Kodak Company |
Camera with multiple spring drive
|
US6713474B2
(en)
|
1998-09-18 |
2004-03-30 |
Abbott Gmbh & Co. Kg |
Pyrrolopyrimidines as therapeutic agents
|
CN100340291C
(zh)
|
1998-10-09 |
2007-10-03 |
路德维格癌症研究院 |
F1t4(VEGFR-3)作为肿瘤显像和抗肿瘤治疗的靶
|
JP2003508009A
(ja)
|
1998-10-19 |
2003-03-04 |
ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ |
新規なニューロピリン/増殖因子結合及びその利用法
|
WO2000024412A2
(en)
|
1998-10-26 |
2000-05-04 |
Ludwig Institute For Cancer Research |
Use of vegf-c or vegf-d gene or protein to prevent restenosis
|
US6958147B1
(en)
|
1998-10-26 |
2005-10-25 |
Licentia Ltd |
Use of VEGF-C to prevent restenosis
|
WO2000037025A2
(en)
|
1998-12-21 |
2000-06-29 |
Ludwig Institute For Cancer Research |
Antibodies to truncated vegf-d and uses thereof
|
DE60039416D1
(de)
|
1999-02-08 |
2008-08-21 |
Human Genome Sciences Inc |
Verwendung vom vaskulären endothelialen wachstumsfaktor 2 (vegf-2)
|
US7223724B1
(en)
|
1999-02-08 |
2007-05-29 |
Human Genome Sciences, Inc. |
Use of vascular endothelial growth factor to treat photoreceptor cells
|
WO2000058511A1
(en)
|
1999-03-26 |
2000-10-05 |
Ludwig Institute For Cancer Research |
Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3)
|
US6764820B2
(en)
|
1999-03-26 |
2004-07-20 |
Ludwig Institute For Cancer Research |
Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3)
|
US6297238B1
(en)
|
1999-04-06 |
2001-10-02 |
Basf Aktiengesellschaft |
Therapeutic agents
|
WO2000061186A1
(en)
|
1999-04-08 |
2000-10-19 |
Arch Development Corporation |
Use of anti-vegf antibody to enhance radiation in cancer therapy
|
CA2365434A1
(en)
|
1999-04-15 |
2000-10-26 |
St. Elizabeth's Medical Center Of Boston |
Angiogenic growth factors for treatment of peripheral neuropathy
|
CN1376197A
(zh)
|
1999-04-26 |
2002-10-23 |
阿文蒂斯药物股份有限公司 |
包含编码血管生成因子的核酸的重组缺损腺病毒治疗肺动脉高血压症的用途
|
US6342221B1
(en)
*
|
1999-04-28 |
2002-01-29 |
Board Of Regents, The University Of Texas System |
Antibody conjugate compositions for selectively inhibiting VEGF
|
US6468543B1
(en)
|
1999-05-03 |
2002-10-22 |
Zymogenetics, Inc. |
Methods for promoting growth of bone using ZVEGF4
|
WO2000073430A2
(de)
*
|
1999-05-27 |
2000-12-07 |
Max-Delbrück-Centrum für Molekulare Medizin |
Vakzine gegen konformationsabhängige antigene sowie gegen antigene, die keine oder nicht ausschliesslich proteine oder peptide sind
|
AU5306700A
(en)
|
1999-06-03 |
2000-12-28 |
Human Genome Sciences, Inc. |
Angiogenic proteins and uses thereof
|
WO2000075329A1
(en)
|
1999-06-07 |
2000-12-14 |
Edwards Lifesciences Corporation |
Targeted angiogenesis
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
AU780052B2
(en)
|
1999-09-17 |
2005-02-24 |
Abbott Gmbh & Co. Kg |
Pyrazolopyrimidines as therapeutic agents
|
US6420378B1
(en)
|
1999-10-15 |
2002-07-16 |
Supergen, Inc. |
Inhibition of abnormal cell proliferation with camptothecin and combinations including the same
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
ES2293973T3
(es)
*
|
2000-02-03 |
2008-04-01 |
Millennium Pharm Inc |
Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
|
EP2338515A3
(de)
*
|
2000-02-10 |
2011-11-16 |
Abbott Laboratories |
Humanes Interleukin-18 bindende Antikörper und Verfahren zu ihrer Herstellung und Verwendung
|
EP1297016B1
(de)
|
2000-05-12 |
2006-03-22 |
Vlaams Interuniversitair Instituut voor Biotechnologie vzw. |
Verwendung von inhibitoren des plazenta wachstumsfactors für die behandlung einer pathologischen angiogenese, pathologischen arteriogenese, entzündung, tumorbildung und/oder gefässdurchlässigkeit (ödem)
|
AU2001263281A1
(en)
|
2000-05-18 |
2001-11-26 |
Genetix Pharmaceuticals, Inc. |
Polyethylene glycol (peg) polymers for the promotion of angiogenesis
|
AU2001261737A1
(en)
|
2000-05-18 |
2001-11-26 |
Genetix Pharmaceuticals, Inc. |
Methods and compositions for promoting angiogenesis using monocytes
|
US7273751B2
(en)
|
2000-08-04 |
2007-09-25 |
Human Genome Science, Inc. |
Vascular endothelial growth factor-2
|
WO2002029082A1
(en)
|
2000-09-29 |
2002-04-11 |
St.Elizabeth's Medical Center |
Endothelial cell mitogen bioassay
|
US20020151489A1
(en)
|
2000-10-02 |
2002-10-17 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Use of lymphangiogenic agents to treat lymphatic disorders
|
JP2004527462A
(ja)
|
2000-11-01 |
2004-09-09 |
ルードヴィッヒ インスティテュート フォー キャンサー リサーチ |
血管新生活性のinvivo刺激
|
US20030211988A1
(en)
|
2001-01-09 |
2003-11-13 |
Epstein Stephen E |
Enhancing lymph channel development and treatment of lymphatic obstructive disease
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
US7402312B2
(en)
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
US20050232921A1
(en)
|
2001-04-13 |
2005-10-20 |
Rosen Craig A |
Vascular endothelial growth factor 2
|
AU2002252631A1
(en)
|
2001-04-13 |
2002-10-28 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
ATE470676T1
(de)
|
2001-04-13 |
2010-06-15 |
Human Genome Sciences Inc |
Anti-vegf-2 antikörper
|
US20030170786A1
(en)
|
2001-04-13 |
2003-09-11 |
Rosen Craig A. |
Vascular endothelial growth factor 2
|
US7981863B2
(en)
|
2001-09-19 |
2011-07-19 |
Neuronova Ab |
Treatment of Parkinson's disease with PDGF
|
US20040031067A1
(en)
|
2001-10-11 |
2004-02-12 |
Meenhard Herlyn |
Regulation of human skin healing
|
US20030139333A1
(en)
|
2002-01-18 |
2003-07-24 |
Genetix Pharmaceuticals, Inc. |
Methods and compositions for promoting angiogenesis
|
US20030158132A1
(en)
|
2002-01-22 |
2003-08-21 |
Genvec, Inc. |
Method for enhancing bone density or formation
|
US20030225098A1
(en)
|
2002-03-21 |
2003-12-04 |
Hirst Gavin C. |
Kinase inhibitors
|
US20030199525A1
(en)
|
2002-03-21 |
2003-10-23 |
Hirst Gavin C. |
Kinase inhibitors
|
WO2003097660A1
(en)
|
2002-04-12 |
2003-11-27 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
JP3906747B2
(ja)
|
2002-06-14 |
2007-04-18 |
株式会社日立製作所 |
低沸点燃料を使用する燃料供給装置およびその制御方法
|
US20040120950A1
(en)
|
2002-12-20 |
2004-06-24 |
Kari Alitalo |
Modulation of VEGF-C/VEGFR-3 interactions in the treatment of rheumatoid arthritis
|
WO2005016963A2
(en)
|
2003-06-12 |
2005-02-24 |
Ludwig Institute For Cancer Research |
Heparin binding veger-3 ligands
|
ATE507240T1
(de)
|
2004-03-05 |
2011-05-15 |
Vegenics Pty Ltd |
Materialien und verfahren für wachstumsfaktorbindende konstrukte
|
US11284893B2
(en)
|
2019-04-02 |
2022-03-29 |
Covidien Lp |
Stapling device with articulating tool assembly
|